VERTEX PHARMACEUTICALS INC / MA Derivative Liability, Current
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Derivative Liability, Current of $79.40 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-02-13
- 2025-12-31: Derivative Liability, Current $79.40M.
- 2024-12-31: Derivative Liability, Current $0.00.
- 2011-09-30: Derivative Liability, Current $94.16M.
- 2011-06-30: Derivative Liability, Current $87.13M.
| Period end | Derivative Liability, Current |
|---|---|
| 2025-12-31 | $79.40M 10-K · filed 2026-02-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-13 |
| 2011-09-30 | $94.16M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $87.13M 10-Q · filed 2011-08-09 |
| 2011-03-31 | $84.89M 10-Q · filed 2011-05-06 |
| 2010-12-31 | $77.80M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |